HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy-Reference-Cited by-同舟云学术

HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy

Published:2002-01 Issue:1 Volume:4 Page:41-48
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Chen F.E.,Aubert G.,Travers P.,Dodi I.A.,Madrigal J.A.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference37 articles.

1. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies;Couriel;Bone Marrow Transplant,1996

2. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor;Walter;N Engl J Med,1995

3. T cell therapy of human CMV and EBV infection in immunocompromised hosts;Riddell;Rev Med Virol,1997

4. Use of gene-modified virus-specific T lymphocytes to control Epstein–Barrvirus-related lymphoproliferation;Rooney;Lancet,1995

5. Long-term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes;Heslop;Nat Med,1996

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy;Blood Advances;2022-08-22

2. Effectiveness and outcomes of 2 therapeutic interventions for cardiac tamponade;Medicine;2020-07-17

3. Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2018-04-10

4. Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant;International Immunopharmacology;2017-02

5. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2016-11-17